A 24 week pilot, double-blind, randomized, parallel, placebo controlled study of memantine and constraint-induced language therapy in chronic poststroke aphasia: Correlation with cognitive evoked potentials during recovery

Trial Profile

A 24 week pilot, double-blind, randomized, parallel, placebo controlled study of memantine and constraint-induced language therapy in chronic poststroke aphasia: Correlation with cognitive evoked potentials during recovery

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Memantine (Primary)
  • Indications Aphasia
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Apr 2015 Pooled analysis results of this trial and other two 24-Week , placebo-controlled trials presented at the 67th Annual Meeting of the American Academy of Neurology.
    • 10 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top